Clinical trial
Buprenorphine and Integrated HIV Care
NCT00317460 · Yale University, Other · Completed
Key facts
| NCT number | NCT00317460 |
|---|---|
| Title | Buprenorphine and Integrated HIV Care |
| Official title | On-Site Addiction Treatment With Buprenorphine in HIV Clinical Care Settings |
| Lead sponsor | Yale University, Other |
| Collaborators | The New York Academy of Medicine |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Substance-related Disorders, Drug Addiction, Human Immunodeficiency Virus, AIDS, HIV Infections |
| Intervention type | Behavioral, Other |
| Interventions | Physician Management, Counseling |
| Enrollment | 52 |
| Start date | Sep 1, 2005 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 1, 2012 |
| First posted | Apr 24, 2006 |
| Last update posted | Apr 3, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: